Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1380Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REGNO:BG0119006 | - |
| dc.date.accessioned | 2023-03-30T14:31:19Z | - |
| dc.date.available | 2023-03-30T14:31:19Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1380 | - |
| dc.description.abstract | Background: Methotrexate (MTX) is recommended as first-line therapy in patients with active RA as monotherapy or in combination with other disease-modifying anti-rheumatic drugs (DMARDs). Despite being considered a safe drug, some toxicities of MTX are inevitable and patients are stopping further treatment with MTX for the same. Objective: To evaluate the safety profile of Methotrexate in patients with Rheumatoid Arthritis (RA). | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.title | Safety profile of methotrexate in patients with Rheumatoid arthritis | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | General Medicine MD | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| REG NO BG0119006.pdf | 3.7 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.